BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28542715)

  • 1. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10
    Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J;
    Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
    Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
    Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
    Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
    Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
    Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
    J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applicability of the WHO classification in paediatric AML. A NOPHO-AML study.
    Sandahl JD; Kjeldsen E; Abrahamsson J; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Br J Haematol; 2015 Jun; 169(6):859-67. PubMed ID: 25819835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
    Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic leukapheresis: 9-year experience in a University Hospital.
    Parra Salinas IM; González Rodriguez VP; García-Erce JA
    Blood Transfus; 2015 Jan; 13(1):46-52. PubMed ID: 24960648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
    Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H
    Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
    Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
    Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxemia During Extreme Hyperleukocytosis: How Spurious?
    Van de Louw A; Desai RJ; Schneider CW; Claxton DF
    Respir Care; 2016 Jan; 61(1):8-14. PubMed ID: 26420901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
    Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G
    Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
    Vaitkevičienė G; Forestier E; Hellebostad M; Heyman M; Jonsson OG; Lähteenmäki PM; Rosthoej S; Söderhäll S; Schmiegelow K;
    Eur J Haematol; 2011 Jan; 86(1):38-46. PubMed ID: 21077959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.
    Karlsson L; Forestier E; Hasle H; Jahnukainen K; Jónsson ÓG; Lausen B; Norén Nyström U; Palle J; Tierens A; Zeller B; Abrahamsson J
    Br J Haematol; 2017 Aug; 178(4):592-602. PubMed ID: 28439893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.